Friday, December 13, 2019

 


Aurora Cannabis Inc
(TSX: ACB.TO) Add to Watchlist
$3.47
+0.03 (+0.87%)
as of Dec 13, 2019

Last 3.47
Change +0.03 (+0.87%)
Open 3.46
Prev. Close 3.44
Today's Range
3.42 3.61
52wk Range
2.82 13.67
Volume 9,966,248
Avg Volume 12,946,713

Recent Headlines
TORONTO — Some of the most active companies traded Friday on the Toronto Stock Exchange:  (full story)
ACB.TO: 3.47 (+0.03), CNQ.TO: 40.08 (-0.04), ECA.TO: 5.56 (+0.04), VLE.TO: 0.48 (-0.56), BBD-B.TO: 1.92 (unch), POW.TO: 34.42 (+2.52), CNR.TO: 118.72 (-0.60)
The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Aurora Cannabis Inc. ("Aurora" or "the Company") (NYSE: ACB) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by th  (full story)
ACB.TO: 3.47 (+0.03), ACB: 2.63 (+0.03)
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may contact Peretz Bronstein, Esq. or his Investor Relat  (full story)
ACB.TO: 3.47 (+0.03), ACB: 2.63 (+0.03), BAX: 83.96 (+0.45), HEXO: 2.24 (+0.01)
InvestorsObserver issues critical PriceWatch Alerts for ACB, FIT, NIO, SPRT, and T.  (full story)
T: 38.26 (-0.09), ACB.TO: 3.47 (+0.03), FIT: 6.59 (-0.07), NIO: 2.39 (+0.12)
Performance Comparison
Name Today 3-Month 1-Year
ACB.TO +0.87% -42.26% -54.40%
$TXCX +0.33% +3.87% +15.27%
$TXCI +0.25% +3.82% +14.56%
DJIA +0.01% +7.38% +14.38%
S&P 500 +0.01% +8.87% +19.55%

Key Statistics
Annual EPS -0.40
Dividend & Yield -- (--)
P/E Ratio N/A
Market Capitalization, $K 3,613,868
Weighted Alpha -58.55
Standard Deviation +0.11
Profit Margin -1.31%
Beta 1.91

Growth Rates
YTD -48.82%
1-Year -55.74%
3-Year +46.41%
5-Year +706.98%
© 2019 Market data provided and hosted by Barchart Market Data Solutions. Fundamental company data provided by Morningstar and Zacks Investment Research. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.